August–September 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

A three-point scoring system that requires nothing more than a blood count, a brief assessment of a patient’s physical ...

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging. Melbourne (Australia) and Indianapolis, IN (United States) \| September 30, 2026. FDA Fast T ...

“It should be protocol that 100% of your patients with metastatic prostate cancer get germline testing. Full stop. No exceptions,” said Neal D. Shore, MD, FACS.

First predictive evidence in intermediate-risk prostate cancer supporting use of the Decipher test to guide short-term hormone therapy decisions to be presented at ASTRO 2026. SOU ...

There is a moment in a prostate cancer consultation when I sometimes wish I could slow time down. The patient has already been through the blood test, the scan and ...

Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and ...

The FDA cleared the SpaceOAR Flex System, a hydrogel spacer used during prostate cancer radiotherapy, in a 510 (k) supported by the HYDROSPACE trial.

For men, taking measure of your prostate health is a lot like tracking your golf games — and just as personal, Dr. Curtis ...

NRG-GU005: SBRT vs Moderately Hypofractionated IMRT in Localized Prostate Cancer / cancer, cancer care, Cancer research, cancer treatment, clinical trials, ...